Biofrontera gets FDA approval for Ameluz red-light PDT
Biofrontera said the FDA approved Ameluz topical gel with RhodoLED red-light photodynamic therapy for treating superficial basal cell carcinoma in adults.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.